(TXN) Texas Instruments - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 281.410m USD | Total Return: 73.5% in 12m
Avg Turnover: 2.15B
EPS Trend: -74.1%
Qual. Beats: 1
Rev. Trend: -11.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Supp Ema8, Confidence
Texas Instruments Incorporated (TXN) is a global semiconductor manufacturer specializing in analog and embedded processing chips. The company’s Analog segment focuses on power management and signal chain products, while the Embedded Processing segment produces microcontrollers, processors, and wireless connectivity hardware. These components are essential for a wide range of end markets, including industrial, automotive, and personal electronics.
The semiconductor industry is characterized by high capital intensity and cyclical demand, with analog chips specifically benefiting from longer product lifecycles compared to leading-edge digital processors. Texas Instruments maintains a business model focused on internal manufacturing and a diverse customer base, which helps mitigate risks associated with reliance on a single market or consumer trend. Investors may find it useful to examine ValueRay for further data on the companys historical performance.
Founded in 1930 and headquartered in Dallas, Texas, the company utilizes a multi-channel distribution strategy involving direct sales, online platforms, and third-party distributors. Its portfolio includes specialized technologies such as DLP products for high-definition imaging and application-specific integrated circuits (ASICs) for enterprise systems.
- Industrial and automotive sector demand cycles dictate long-term revenue growth
- Capital expenditure for 300mm wafer manufacturing expansion pressures near-term free cash flow
- Analog and embedded processing market share stability maintains industry-leading operating margins
- Inventory correction phases in personal electronics impact quarterly earnings performance
- Geopolitical trade restrictions on high-tech exports influence Chinese market revenue contribution
| Net Income: 5.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 6.51 > 1.0 |
| NWC/Revenue: 58.03% < 20% (prev 66.03%; Δ -8.00% < -1%) |
| CFO/TA 0.23 > 3% & CFO 7.82b > Net Income 5.37b |
| Net Debt (9.63b) to EBITDA (8.62b): 1.12 < 3 |
| Current Ratio: 4.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (914.0m) vs 12m ago -0.22% < -2% |
| Gross Margin: 57.32% > 18% (prev 0.58%; Δ 5.67k% > 0.5%) |
| Asset Turnover: 54.11% > 50% (prev 47.54%; Δ 6.57% > 0%) |
| Interest Coverage Ratio: 11.70 > 6 (EBITDA TTM 8.62b / Interest Expense TTM 556.0m) |
| A: 0.31 (Total Current Assets 13.8b - Total Current Liabilities 3.10b) / Total Assets 34.4b |
| B: 1.53 (Retained Earnings 52.5b / Total Assets 34.4b) |
| C: 0.19 (EBIT TTM 6.51b / Avg Total Assets 34.1b) |
| D: 3.07 (Book Value of Equity 54.1b / Total Liabilities 17.6b) |
| Altman-Z'' = 11.53 = AAA |
| DSRI: 0.64 (Receivables 2.25b/3.06b, Revenue 18.4b/16.0b) |
| GMI: 1.01 (GM 57.32% / 58.02%) |
| AQI: 0.94 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.15 (Revenue 18.4b / 16.0b) |
| TATA: -0.07 (NI 5.37b - CFO 7.82b) / TA 34.4b) |
| Beneish M = -3.32 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 309.21 with a total of 7,129,100 shares traded.
Over the past week, the price has changed by +2.14%,
over one month by +15.32%,
over three months by +45.29% and
over the past year by +73.48%.
Texas Instruments has received a consensus analysts rating of 3.70. Therefore, it is recommended to hold TXN.
- StrongBuy: 14
- Buy: 2
- Hold: 19
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 285.3 | -7.7% |
P/E Trailing = 52.9469
P/E Forward = 39.2157
P/S = 15.2625
P/B = 16.1856
P/EG = 1.4268
Revenue TTM = 18.4b USD
EBIT TTM = 6.51b USD
EBITDA TTM = 8.62b USD
Long Term Debt = 12.9b USD (from longTermDebt, last quarter)
Short Term Debt = 1.15b USD (from shortTermDebt, last quarter)
Debt = 14.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 681.0m
Net Debt = 9.63b USD (calculated: Debt 14.7b - CCE 5.10b)
Enterprise Value = 291b USD (281b + Debt 14.7b - CCE 5.10b)
Interest Coverage Ratio = 11.70 (Ebit TTM 6.51b / Interest Expense TTM 556.0m)
EV/FCF = 78.21x (Enterprise Value 291b / FCF TTM 3.72b)
FCF Yield = 1.28% (FCF TTM 3.72b / Enterprise Value 291b)
FCF Margin = 20.18% (FCF TTM 3.72b / Revenue TTM 18.4b)
Net Margin = 29.11% (Net Income TTM 5.37b / Revenue TTM 18.4b)
Gross Margin = 57.32% ((Revenue TTM 18.4b - Cost of Revenue TTM 7.87b) / Revenue TTM)
Gross Margin QoQ = 58.01% (prev 55.89%)
Tobins Q-Ratio = 8.46 (Enterprise Value 291b / Total Assets 34.4b)
Interest Expense / Debt = 3.77% (Interest Expense 556.0m / Debt 14.7b)
Taxrate = 9.86% (169.0m / 1.71b)
NOPAT = 5.87b (EBIT 6.51b * (1 - 9.86%))
Current Ratio = 4.46 (Total Current Assets 13.8b / Total Current Liabilities 3.10b)
Debt / Equity = 0.88 (Debt 14.7b / totalStockholderEquity, last quarter 16.8b)
Debt / EBITDA = 1.12 (Net Debt 9.63b / EBITDA 8.62b)
Debt / FCF = 2.59 (Net Debt 9.63b / FCF TTM 3.72b)
Total Stockholder Equity = 16.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.75% (Net Income 5.37b / Total Assets 34.4b)
RoE = 32.49% (Net Income TTM 5.37b / Total Stockholder Equity 16.5b)
RoCE = 22.12% (EBIT 6.51b / Capital Employed (Equity 16.5b + L.T.Debt 12.9b))
RoIC = 18.10% (NOPAT 5.87b / Invested Capital 32.4b)
WACC = 10.88% (E(281b)/V(296b) * Re(11.27%) + D(14.7b)/V(296b) * Rd(3.77%) * (1-Tc(0.10)))
Discount Rate = 11.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -38.65 | Cagr: -0.05%
[DCF] Terminal Value 70.24% ; FCFF base≈2.81b ; Y1≈3.23b ; Y5≈4.75b
[DCF] Fair Price = 43.64 (EV 49.3b - Net Debt 9.63b = Equity 39.7b / Shares 910.1m; r=10.88% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -74.10 | EPS CAGR: -12.54% | SUE: 4.0 | # QB: 1
Revenue Correlation: -11.90 | Revenue CAGR: -0.83% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.92 | Chg30d=+21.68% | Revisions=+85% | Analysts=27
EPS next Quarter (2026-09-30): EPS=2.12 | Chg30d=+17.71% | Revisions=+85% | Analysts=27
EPS current Year (2026-12-31): EPS=7.69 | Chg30d=+19.18% | Revisions=+88% | GrowthEPS=+41.0% | GrowthRev=+18.8%
EPS next Year (2027-12-31): EPS=8.94 | Chg30d=+15.56% | Revisions=+87% | GrowthEPS=+16.4% | GrowthRev=+10.9%
[Analyst] Revisions Ratio: +88%